Gastric emptying time and gastric motility in patients with Parkinson's disease
- PMID: 11748735
- DOI: 10.1002/mds.1203
Gastric emptying time and gastric motility in patients with Parkinson's disease
Abstract
Gastrointestinal symptoms such as nausea, abdominal pain, and bloating are frequent complaints of patients with Parkinson's disease (PD). It has been postulated that impaired gastrointestinal function may contribute to the development of motor fluctuations such as delay on and no on in patients with PD. Gastrointestinal impaired function and symptoms may be associated with the disease itself or secondary to levodopa treatment. Thus, we assessed gastric emptying (GE) and gastric motility in PD patients to examine the association between clinical status and gastric function. GE and antral contraction (frequency and amplitude) were evaluated by scintigraphy in 29 patients with mild PD (Hoehn and Yahr [H&Y] stage 1.0-2.0); 22 patients with moderate PD (H&Y stage 2.5-3.0); and 22 healthy volunteers, following the ingestion of a labeled standard meal. Gastric emptying (mean +/- SD of T(1/2)) and antral contraction were not significantly different between patients with mild PD (63.4 +/- 28.8 minutes) and moderate PD (54.7 +/- 25.5 minutes). In the control group, GE was 43.4 +/- 10.8 minutes (range 29.0 - 61.0 minutes). The prevalence of delayed emptying (>61 minutes) was not significantly different in patients with mild disease (48.3%) as compared with patients with moderate disease (36.4%). Antral contraction, both frequency and amplitude, were not significantly different between patients with mild and moderate PD throughout the entire 100 minutes of the study. Untreated patients (n = 28) had mean GE T(1/2) of 59 +/- 30.6 minutes. Patients with smooth response to levodopa showed slower GE (n = 10; 73.6 +/- 25.3 minutes), while treated patients with motor response fluctuations when tested at the on state (n = 13), had much faster GE (49.3 +/- 16.2 minutes). This shortened GE in the on state was similar to the GE of normal volunteers. We conclude that gastric emptying time in patients with PD was delayed compared with control volunteers. It was even slower in patients treated with levodopa. This effect of levodopa treatment was reversed to pseudonormalization (normal GE) at the advanced stages of the disease, when patients developed motor response fluctuation. Other clinical features of PD were not associated with delayed gastric emptying.
Copyright 2001 Movement Disorder Society.
Similar articles
-
Delayed Gastric Emptying in Advanced Parkinson Disease: Correlation With Therapeutic Doses.Clin Nucl Med. 2017 Feb;42(2):83-87. doi: 10.1097/RLU.0000000000001470. Clin Nucl Med. 2017. PMID: 27941374
-
Unchanged gastric emptying and visceral perception in early Parkinson's disease after a high caloric test meal.J Neurol. 2015 Aug;262(8):1946-53. doi: 10.1007/s00415-015-7799-z. Epub 2015 Jun 6. J Neurol. 2015. PMID: 26048686 Clinical Trial.
-
Is there a difference in gastric emptying between Parkinson's disease patients under long-term L-dopa therapy with and without motor fluctuations? An analysis using the 13C-acetate breath test.J Neurol. 2009 Dec;256(12):1972-6. doi: 10.1007/s00415-009-5220-5. J Neurol. 2009. PMID: 19575260
-
[Gastrointestinal dysfunction has important implications for plasma L-dopa concentrations in Parkinson's disease].Rinsho Shinkeigaku. 2013;53(11):1382-5. doi: 10.5692/clinicalneurol.53.1382. Rinsho Shinkeigaku. 2013. PMID: 24291998 Review. Japanese.
-
Irregular gastrointestinal drug absorption in Parkinson's disease.Expert Opin Drug Metab Toxicol. 2008 Feb;4(2):193-203. doi: 10.1517/17425255.4.2.193. Expert Opin Drug Metab Toxicol. 2008. PMID: 18248312 Review.
Cited by
-
Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET.Brain. 2015 Mar;138(Pt 3):653-63. doi: 10.1093/brain/awu369. Epub 2014 Dec 23. Brain. 2015. PMID: 25539902 Free PMC article.
-
Microbial treatment: the potential application for Parkinson's disease.Neurol Sci. 2019 Jan;40(1):51-58. doi: 10.1007/s10072-018-3641-6. Epub 2018 Nov 10. Neurol Sci. 2019. PMID: 30415447 Review.
-
The use of enteral access for continuous delivery of levodopa-carbidopa in patients with advanced Parkinson's disease.United European Gastroenterol J. 2017 Feb;5(1):60-68. doi: 10.1177/2050640616650804. Epub 2016 Jun 23. United European Gastroenterol J. 2017. PMID: 28405323 Free PMC article.
-
Model-based dietary optimization for late-stage, levodopa-treated, Parkinson's disease patients.NPJ Syst Biol Appl. 2016 Jun 16;2:16013. doi: 10.1038/npjsba.2016.13. eCollection 2016. NPJ Syst Biol Appl. 2016. PMID: 28725472 Free PMC article.
-
An Observational Study of the Effect of Levodopa-Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson's Disease Patients.Adv Ther. 2017 Jul;34(7):1741-1752. doi: 10.1007/s12325-017-0571-2. Epub 2017 Jun 19. Adv Ther. 2017. PMID: 28631218 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical